Works matching AU Greasley, Peter J.

Results: 41
    1

    Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 8, p. 4415, doi. 10.1111/dom.16478
    By:
    • Beernink, Jelle M.;
    • Jongs, Niels;
    • Mosterd, Charlotte M.;
    • Scholtes, Rosalie A.;
    • Caldwell‐McGee, Alyssa;
    • Casillas, Daniel;
    • Driscoll, Lynette;
    • Greasley, Peter J.;
    • Karlsson, Cecilia;
    • Hammarstedt, Ann;
    • Sridhar, Vikas S.;
    • Muskiet, Marcel H. A.;
    • Laverman, Gozewijn D.;
    • Cherney, David Z. I.;
    • Bjornstad, Petter;
    • van Raalte, Daniel H.;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    2
    3
    4

    Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1578, doi. 10.1111/dom.14729
    By:
    • Sen, Taha;
    • Scholtes, Rosalie;
    • Greasley, Peter J.;
    • Cherney, David Z. I.;
    • Dekkers, Claire C. J.;
    • Vervloet, Marc;
    • Danser, Alexander H. J.;
    • Barbour, Sean J.;
    • Karlsson, Cecilia;
    • Hammarstedt, Ann;
    • Li, Qiang;
    • Laverman, Gozewijn D.;
    • Bjornstad, Petter;
    • van Raalte, Daniel H.;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    5

    Renal haemodynamic response to sodium‐glucose cotransporter‐2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials.

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1961, doi. 10.1111/dom.14411
    By:
    • van der Aart‐van der Beek, Annemarie B.;
    • Cherney, David;
    • Laverman, Gozewijn D.;
    • Stefansson, Bergur;
    • Raalte, Daniel H.;
    • Hoogenberg, Klaas;
    • Reyner, Daniel;
    • Li, Qiang;
    • Di Tanna, Gian Luca;
    • Greasley, Peter J.;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    6
    7

    Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2684, doi. 10.1111/dom.13858
    By:
    • Yakovleva, Tatiana;
    • Sokolov, Victor;
    • Chu, Lulu;
    • Tang, Weifeng;
    • Greasley, Peter J.;
    • Peilot Sjögren, Helena;
    • Johansson, Susanne;
    • Peskov, Kirill;
    • Helmlinger, Gabriel;
    • Boulton, David W.;
    • Penland, Robert C.
    Publication type:
    Article
    8
    9

    Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 12, p. 2684, doi. 10.1111/dom.13858
    By:
    • Yakovleva, Tatiana;
    • Sokolov, Victor;
    • Chu, Lulu;
    • Tang, Weifeng;
    • Greasley, Peter J.;
    • Peilot Sjögren, Helena;
    • Johansson, Susanne;
    • Peskov, Kirill;
    • Helmlinger, Gabriel;
    • Boulton, David W.;
    • Penland, Robert C.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.

    Published in:
    Nephrology Dialysis Transplantation, 2024, v. 39, n. 3, p. 414, doi. 10.1093/ndt/gfad183
    By:
    • Heerspink, Hiddo J L;
    • Greasley, Peter J;
    • Ahlström, Christine;
    • Althage, Magnus;
    • Dwyer, Jamie P;
    • Law, Gordon;
    • Wijkmark, Emma;
    • Lin, Min;
    • Mercier, Anne-Kristina;
    • Sunnåker, Mikael;
    • Turton, Michelle;
    • Wheeler, David C;
    • Ambery, Philip
    Publication type:
    Article
    16
    17

    Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium.

    Published in:
    Nephrology Dialysis Transplantation, 2020, v. 35, n. 12, p. 2059, doi. 10.1093/ndt/gfaa121
    By:
    • Levin, Anna;
    • Reznichenko, Anna;
    • Witasp, Anna;
    • Liu, Peidi;
    • Greasley, Peter J;
    • Sorrentino, Antonio;
    • Blondal, Thorarinn;
    • Zambrano, Sonia;
    • Nordström, Johan;
    • Bruchfeld, Annette;
    • Barany, Peter;
    • Ebefors, Kerstin;
    • Erlandsson, Fredrik;
    • Patrakka, Jaakko;
    • Stenvinkel, Peter;
    • Nyström, Jenny;
    • Wernerson, Annika
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability.

    Published in:
    Science Translational Medicine, 2018, v. 10, n. 456, p. 1, doi. 10.1126/scitranslmed.aam6474
    By:
    • King, Andrew J.;
    • Siegel, Matthew;
    • He, Ying;
    • Nie, Baoming;
    • Wang, Ji;
    • Koo-McCoy, Samantha;
    • Minassian, Natali A.;
    • Jafri, Qumber;
    • Pan, Deng;
    • Kohler, Jill;
    • Kumaraswamy, Padmapriya;
    • Kozuka, Kenji;
    • Lewis, Jason G.;
    • Dragoli, Dean;
    • Rosenbaum, David P.;
    • O'Neill, Debbie;
    • Plain, Allein;
    • Greasley, Peter J.;
    • Jönsson-Rylander, Ann-Cathrine;
    • Karlsson, Daniel
    Publication type:
    Article
    25
    26
    27

    Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease.

    Published in:
    Clinical Pharmacokinetics, 2021, v. 60, n. 4, p. 517, doi. 10.1007/s40262-020-00956-1
    By:
    • van der Aart-van der Beek, Annemarie B.;
    • Koomen, Jeroen V.;
    • Dekkers, Claire C. J.;
    • Barbour, Sean J.;
    • Boulton, David W.;
    • Gansevoort, Ron T.;
    • Greasley, Peter J.;
    • Abdul Gafor, Abdul Halim;
    • Laverman, Gozewijn D.;
    • Li, Qiang;
    • Lim, Soo Kun;
    • Stevens, Jasper;
    • Vervloet, Marc G.;
    • Singh, Sunita;
    • Cattran, Daniel C.;
    • Reich, Heather N.;
    • Cherney, David Z. I.;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    28
    29
    30

    Gastric Bypass vs Diet and Cardiovascular Risk Factors: A Nonrandomized Controlled Trial.

    Published in:
    JAMA Surgery, 2024, v. 159, n. 9, p. 971, doi. 10.1001/jamasurg.2024.2162
    By:
    • Karlsson, Cecilia;
    • Johnson, Line Kristin;
    • Greasley, Peter J.;
    • Retterstøl, Kjetil;
    • Hedberg, Jonatan;
    • Hall, Martin;
    • Hawker, Noele;
    • Robertsen, Ida;
    • Havsol, Jesper;
    • Hertel, Jens Kristoffer;
    • Sandbu, Rune;
    • Skovlund, Eva;
    • Olsen, Thomas;
    • Christensen, Hege;
    • Jansson-Löfmark, Rasmus;
    • Andersson, Shalini;
    • Åsberg, Anders;
    • Hjelmesæth, Jøran
    Publication type:
    Article
    31
    32

    Effect of AZD9977 and spironolactone on serum potassium in heart failure with preserved or mildly reduced ejection fraction, and renal impairment: A randomized trial.

    Published in:
    CTS: Clinical & Translational Science, 2022, v. 15, n. 10, p. 2493, doi. 10.1111/cts.13377
    By:
    • Squire, Iain B.;
    • Gabrielsen, Anders;
    • Greasley, Peter J.;
    • Wernevik, Linda;
    • Hartleib‐Geschwindner, Judith;
    • Holden, Julie;
    • Johansson, Susanne;
    • Rudvik, Anna;
    • Sánchez, José;
    • Bamberg, Krister;
    • Melin, Johanna;
    • Whittaker, Andrew
    Publication type:
    Article
    33
    34

    Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.

    Published in:
    Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-02027-8
    By:
    • Koshino, Akihiko;
    • Neuen, Brendon L.;
    • Jongs, Niels;
    • Pollock, Carol;
    • Greasley, Peter J.;
    • Andersson, Eva-Marie;
    • Hammarstedt, Ann;
    • Karlsson, Cecilia;
    • Langkilde, Anna Maria;
    • Wada, Takashi;
    • Heerspink, Hiddo J.L.
    Publication type:
    Article
    35
    36

    Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HF.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1856, doi. 10.1002/ejhf.2649
    By:
    • Adamson, Carly;
    • Cowan, Lorna M.;
    • de Boer, Rudolf A.;
    • Diez, Mirta;
    • Drożdż, Jarosław;
    • Dukát, Andre;
    • Inzucchi, Silvio E.;
    • Køber, Lars;
    • Kosiborod, Mikhail N.;
    • Ljungman, Charlotta E.A.;
    • Martinez, Felipe A.;
    • Ponikowski, Piotr;
    • Sabatine, Marc S.;
    • Lindholm, Daniel;
    • Bengtsson, Olof;
    • Boulton, David W.;
    • Greasley, Peter J.;
    • Langkilde, Anna Maria;
    • Sjöstrand, Mikaela;
    • Solomon, Scott D.
    Publication type:
    Article
    37
    38
    39
    40
    41